Identifiez-vous
Groupes
Chercheurs
Financement
Résultats
Julen
Oyarzabal Santamarina
Chercheur jusqu' 2018
Children's Cancer Therapy Development Institute
Beaverton, Estados Unidos
Tu es dans
Collaborations
Children's Cancer Therapy Development Institute
Publications en collaboration avec des chercheurs de Children's Cancer Therapy Development Institute (2)
2024
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
Contacter
Avertissement légal
Aide
translate
fr
arrow_drop_down
translate
fr
arrow_drop_down
es
ca
eu
gl
en
de